Can a Nurse Practitioner or PA Supervise Contrast Administration? What CMS Says

‍

This question comes up constantly in imaging center compliance discussions, and the answer is more nuanced than a simple yes or no. Facilities exploring virtual supervision arrangements often ask whether a nurse practitioner or physician assistant on staff could fill the supervision role for contrast-enhanced CT and MRI, potentially reducing their dependence on a physician for every contrast session.

CMS does authorize certain non-physician practitioners to supervise Level 2 diagnostic tests, including contrast-enhanced studies. But the authorization comes with two conditions that significantly limit how broadly it applies in practice: the practitioner must be acting within their state-authorized scope of practice, and the facility must be operating in a setting where that supervision is permitted under applicable billing and regulatory rules.

Here is what the regulation actually says and what it means for how your facility structures contrast supervision.

What the CMS Rule Authorizes

Under 42 CFR §410.32, which governs diagnostic test supervision requirements, CMS established that Level 2 diagnostic tests, including contrast-enhanced CT and MRI, require direct supervision. Historically, only physicians could fulfill that requirement.

Beginning with rule changes that took effect in 2021 and made permanent under the 2026 Physician Fee Schedule and OPPS Final Rules, CMS extended the authorization to a defined category of non-physician practitioners (NPPs). The rule now explicitly lists the practitioners who may supervise Level 2 diagnostic tests requiring contrast:

• Nurse practitioners (NPs)
• Clinical nurse specialists (CNSs)
• Physician assistants (PAs)
• Certified registered nurse anesthetists (CRNAs)
• Certified nurse-midwives (CNMs)

Each of these practitioners is permitted to provide direct supervision for contrast studies, including virtually under the permanent rule effective January 1, 2026, to the extent they are authorized to do so under their scope of practice and applicable state law.

The critical phrase: ‘To the extent that those non-physician practitioners are authorized to supervise diagnostic tests under their scope of practice and applicable state law.’ This language, drawn directly from the CMS rule, is what determines whether an NP or PA at your specific facility, in your specific state, can legally fill the supervision role.

The Two Conditions That Limit How Broadly This Applies

Condition 1: State scope of practice authorization

NP and PA scope of practice is governed by state law, and it varies significantly. Some states grant NPs full practice authority, meaning they can supervise a wide range of clinical procedures independently. Other states require a collaborative or supervisory agreement with a physician before an NP can perform certain functions. PA scope of practice similarly varies from state to state, with some states allowing substantial independent authority and others requiring physician oversight of most PA activities.

Whether an NP or PA at your facility is legally authorized to supervise contrast administration specifically, in your state, depends on how your state defines their scope of practice. Many states have not addressed this question directly in their scope-of-practice statutes, which creates ambiguity. Before relying on an NP or PA for contrast supervision, facilities should confirm with their legal counsel or state licensing board whether that supervision function falls within the practitioner's authorized scope.

Condition 2: Setting and billing context

The NPP authorization applies in physician offices and Independent Diagnostic Testing Facilities (IDTFs) under the Physician Fee Schedule, and in hospital outpatient departments under the OPPS Final Rule. However, the billing implications differ by setting. In physician office settings, contrast studies supervised by NPPs may be billed as incident-to services under the supervising physician's National Provider Identifier, or billed under the NPP's own NPI at a reduced rate. Facilities should confirm with their billing team how NPP-supervised contrast studies should be coded and billed in their specific operating context.

Summary: Who Can Supervise Contrast Under CMS Rules

/What This Means Practically for Imaging Centers

The NPP authorization is real and it matters in certain settings, particularly for facilities that already employ NPs or PAs with broad scope-of-practice authority in states where contrast supervision falls within their authorized functions. Washington's HB 2113, which took effect June 2026, is a specific example: it explicitly permits ARNPs and PAs to directly supervise contrast administration under state law, which aligns cleanly with CMS authorization and removes the ambiguity that exists in most states.

For most facilities in most states, however, the practical answer is more limited. The scope-of-practice condition creates meaningful uncertainty, and many facilities that have explored this path have concluded that the legal and billing complexity of relying on NPP supervision makes it operationally difficult to implement reliably.

The more common and consistently compliant approach is physician supervision, provided either on-site or virtually under the CMS permanent rule. A contracted virtual supervision service provides qualified physician oversight across all operating hours without the state-by-state scope-of-practice analysis that NPP supervision requires.

The Questions to Ask Before Relying on NPP Supervision

If your facility is evaluating whether an NP or PA on staff could fill the contrast supervision role, the following questions should be answered before implementing that arrangement:

• State scope of practice: Has your state's licensing board or medical practice act explicitly addressed whether NPs or PAs can supervise contrast administration as a diagnostic test function? If not, legal counsel should review the applicable statutes and regulations.
• Collaborative agreement requirements: If your state requires a collaborative or supervisory agreement between the NP or PA and a physician for certain functions, does that agreement cover contrast supervision specifically?
• Billing implications: How will contrast studies supervised by an NPP be coded and billed? Confirm with your billing team before implementing.
• Documentation: CMS requires documentation of supervision for Medicare-billable contrast studies. Confirm that your supervision records will capture the NPP's credentials, the nature of their authorization, and the basis for their eligibility to supervise in your state.
• State-specific legislation: Some states, like Washington, have enacted legislation that explicitly authorizes NPP supervision of contrast studies. If your state has done so, confirm that your arrangement meets the specific conditions the legislation imposes.

The Short Answer

CMS authorizes nurse practitioners, physician assistants, clinical nurse specialists, CRNAs, and CNMs to supervise Level 2 contrast studies, including virtually under the permanent 2026 rule. The authorization is real but conditional: it applies only to the extent the practitioner is authorized to perform that function under their state scope of practice and applicable state law.

For facilities where that condition is clearly met, NPP supervision is a viable option. For facilities in states where the scope question is ambiguous, physician supervision, provided on-site or through a contracted virtual supervision service, remains the cleaner and more consistently compliant path.

ContrastConnect provides physician-led virtual supervision that satisfies the CMS direct supervision standard without the state-by-state scope-of-practice analysis that NPP supervision requires. If you are working through a supervision compliance question for your facility, our team is glad to walk through what a physician supervision arrangement looks like for your specific operating context.

‍